SelectScience reports how researchers at Stony Brook University are working to fully understand the role of a ‘double-agent’ protein in breast cancer with a view to developing new treatments
With breast cancer, the most common form of cancer in women globally, scientists at Stony Brook University, are on a mission to establish how the disease starts and progresses at the detailed molecular level.
Dr. Chioma Okeoma, an associate professor in the School of Medicine, leads a research team dedicated to investigating how, in response to external attack, the host immune system can act as a double-edged sword—preventing viral infection, while at the same time promoting tumor development.
One protein, in particular, encapsulates that paradox—read the full article on SelectScience to find out more.
—SelectScience
Add comment